isopimaric-acid has been researched along with Triple-Negative-Breast-Neoplasms* in 1 studies
1 other study(ies) available for isopimaric-acid and Triple-Negative-Breast-Neoplasms
Article | Year |
---|---|
Isopimaric acid, an ion channel regulator, regulates calcium and oxidative phosphorylation pathways to inhibit breast cancer proliferation and metastasis.
Breast cancer is the globally most common malignant tumor and the biggest threat to women. Even though the diagnosis and treatment of breast cancer are progressing continually, a large number of breast cancer patients eventually develop a metastatic tumor, especially triple-negative breast cancer (TNBC). Recently, metal ion homeostasis and ion signaling pathway have become important targets for cancer therapy. In this study, We analyzed the effects and mechanisms of isopimaric acid (IPA), an ion channel regulator, on the proliferation and metastasis of breast cancer cells (4 T1, MDA-MB-231and MCF-7) by cell functional assay, flow cytometry, western blot, proteomics and other techniques in vitro and in vivo. Results found that IPA significantly inhibited the proliferation and metastasis of breast cancer cells (especially 4 T1). Further studies on the anti-tumor mechanism of IPA suggested that IPA might affect EMT and Wnt signaling pathways by targeting mitochondria oxidative phosphorylation and Ca Topics: Apoptosis; Calcium; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Ion Channels; Oxidative Phosphorylation; Triple Negative Breast Neoplasms; Wnt Signaling Pathway | 2023 |